COMPANY INFO
There are two companies named Centaur with distinct profiles. The first, Centaur Pharmaceuticals Private Limited, was founded in 1978 in Mumbai, India. It has 3,523 employees and operates in the pharmaceutical industry, developing and manufacturing branded formulations and APIs. Its website is www.centaurpharma.com. The second, Centaur Analytics, Inc., was founded in 2014 in the United States. It provides a cognitive technology-based integrated hardware and software platform for real-time monitoring and data analytics of stored crops to reduce harvest spoilage. Its website is centaur.ag.
Centaur Pharmaceuticals Private Limited is a leading pharmaceutical company founded in 1978 in Mumbai, India, with over 3,500 employees. Centaur specializes in developing and manufacturing branded formulations and APIs, serving clients globally in the healthcare sector.
The Centaur Pharmaceuticals Private Limited management team brings together decades of expertise across fund administration, finance, technology, compliance, and operations. The company’s executives possess diverse backgrounds from top financial institutions, global technology firms, and industry‐leading service providers. Through their collective leadership, Centaur Pharmaceuticals Private Limited’s management team continually drives strategic growth, operational excellence, and regulatory compliance, strengthening the company's reputation and expanding its international footprint.
As Senior Vice President of Fund Accounting since November 2022, Brian Johnston leads global fund accounting operations for alternative investment funds at Centaur Pharmaceuticals Private Limited, driving process improvements and system enhancements that have improved reporting accuracy and client satisfaction across the company’s seven international offices. Brian Johnston’s leadership in fund accounting has played a crucial role in supporting scalable operations and ensuring compliance with global financial standards, directly impacting Centaur Pharmaceuticals Private Limited’s ability to service its diverse clientele efficiently.
Johnston holds a Master’s in Public Administration from Hibernia College, a Bachelor’s in Business Studies from Dublin City University, and certifications including CFA Level 1, a Diploma in Investment Funds, and a Harvard Certificate in Leadership. His 20-year career spans senior roles at U.S. Bank, Northern Trust, Susquehanna International Group, Daiwa Securities, and Capita, where he spearheaded teams in fund administration, middle office, and compliance across Europe and North America.
As Group CFO since 2024, Louise Lawlor oversees Centaur Pharmaceuticals Private Limited’s global finance, treasury, and risk management, leading capital planning and financial reporting that have strengthened regulatory compliance and enhanced profitability. Louise Lawlor’s stewardship has helped streamline financial operations and implement best practices across the organization, further embedding financial rigor into Centaur Pharmaceuticals Private Limited’s leadership culture.
Lawlor earned a Bachelor’s in Accounting from Dublin City University and is a Chartered Accountant. She joined Centaur Pharmaceuticals Private Limited in 2019 as Head of Finance and previously held leadership finance roles at BNY Mellon and Citi Hedge Fund Services, where she implemented ERP integrations and optimized P&L processes for hedge fund clients.
As COO – Bermuda since 2024, Marc Weaver manages Bermuda operations, streamlining operational workflows and leading a regional team that expanded Centaur Pharmaceuticals Private Limited’s Bermuda fund administration business by 25% in 12 months. Under Marc Weaver’s leadership, the Bermuda office enhanced client responsiveness and grew its presence as a strategic market for insurance-linked securities and fund services.
Weaver holds a Bachelor’s in Finance from University College Dublin. Before Centaur Pharmaceuticals Private Limited, he served as Operations Director at Maples Group and led global fund services teams at SS&C GlobeOp. His career of over 15 years includes roles in fund accounting, operations management, and client service at major financial institutions.
As CTO, Neil Stone-Wigg drives Centaur Pharmaceuticals Private Limited’s technology vision, implementing scalable cloud infrastructure and a proprietary client portal that reduced client onboarding times by 40% and improved data security. Neil Stone-Wigg is recognized within the Centaur Pharmaceuticals Private Limited leadership team for his strategic oversight of digital transformation and information security best practices.
Stone-Wigg holds an M.Sc. in Computer Science from Imperial College London and is a Certified Information Systems Security Professional (CISSP). He led global IT transformation projects at State Street and Northern Trust, with 18 years’ experience in financial technology architecture, cybersecurity, and digital platforms.
Francois Myburgh oversees operations for Centaur Pharmaceuticals Private Limited in the Philippines, optimizing client service standards and scaling an efficient operations centre to support global fund administration. Francois Myburgh’s focus on operational excellence ensures that Centaur Pharmaceuticals Private Limited’s service delivery remains robust as the business grows internationally.
He holds BCom and BCom (Hons) in Accounting/Internal Audit from the University of Pretoria, and is a Certified Internal Auditor. His career includes Senior VP & Operations Manager at Centaur Bermuda, plus leadership roles in fund accounting at J.P. Morgan, Apex Fund Services, and Citi Hedge Fund Services.
Alison Buss leads the offshore corporate secretarial division, driving governance and compliance processes to ensure regulatory adherence and best practices in corporate administration at Centaur Pharmaceuticals Private Limited. Her commitment to strong governance reinforces the company’s market credibility and operational transparency.
A Chartered Secretary with degrees in Legal Theory and English from Rhodes University, Buss spent 13 years at Centaur Pharmaceuticals Private Limited, advancing from Corporate Services Manager to Head of Corporate Services before joining Waystone in 2022. She began her career at Citi Hedge Fund Services Ireland.
As Head of Investor Services, Bermuda, Neil MacGuinness supervises operations for hedge, private equity, and ILS funds, introducing bespoke workflow and reporting platforms that elevated transparency and client access for Centaur Pharmaceuticals Private Limited’s clients. He has played a key role in enhancing client engagement and service innovation.
MacGuinness holds a degree in Business Administration and began his career in 2002. He was Head of Investor Services at Centaur Bermuda before its acquisition, and has held senior roles at Horseshoe Fund Services, Citi Hedge Fund Services, State Street, and BISYS Hedge Fund Services.
As CEO in Luxembourg since 2024, Antonio Frias leads strategy and operations for Centaur Pharmaceuticals Private Limited’s Luxembourg entity, driving growth in fund accounting services and spearheading IFRS-aligned reporting frameworks. Under his leadership, the Luxembourg office has strengthened its service suite and regulatory positioning in Europe.
Frias holds a CPA in Accounting from UCAB and a BSc from Colegio La Salle. He has led finance teams at Waystone and Centaur Pharmaceuticals Private Limited, and previously held senior roles at JPMorgan Chase and Franklin Templeton.
Eric Bertrand manages global operations and integration for Waystone post-Centaur acquisition, standardizing processes and enhancing operational resilience across regions for Centaur Pharmaceuticals Private Limited. His experience ensures alignment of strategy, processes, and culture throughout the organization.
A Chartered Accountant (CA, CPA) with a BAA from Université de Sherbrooke, Bertrand was a Founding Partner & Director at Centaur Pharmaceuticals Private Limited for over 13 years, and held senior finance leadership positions at Citi Hedge Fund Services and Cossette Communications.
As Managing Director, Gerry Salucci oversees business development and client relationship management, expanding Centaur Pharmaceuticals Private Limited’s market presence in Europe and North America. His efforts have been instrumental in strengthening existing client relationships and winning new mandates for the company.
Salucci holds a Master’s in Finance and began his career at Capita. He joined Centaur Pharmaceuticals Private Limited as a Partner and Director of Business Development, and previously led teams at Northern Trust and Susquehanna International Group.
The Centaur Pharmaceuticals Private Limited management team combines deep sectoral experience with a commitment to operational excellence and client-centric innovation. The company's structure leverages global talent across finance, technology, operations, and governance, with regional leaders ensuring local market expertise and service delivery. This integrated approach allows Centaur Pharmaceuticals Private Limited executives to drive sustainable growth while adhering to the highest standards of compliance and industry best practice.
Websets is a powerful natural language search and data enrichment tool that helps you research executive teams for any company. Whether you're analyzing the Centaur Pharmaceuticals Private Limited leadership team or exploring management structures at other organizations, Websets provides comprehensive insights into executive backgrounds, roles, and team dynamics.
With Websets, you can access detailed executive team profiles, management structures, and leadership insights through intuitive natural language queries. Sign up now to enhance your executive team research capabilities.